Embecta 

$8.93
61
+$0.08+0.9% Monday 20:00

Statistics

Day High
9.02
Day Low
8.73
52W High
15.55
52W Low
8.47
Volume
804,679
Avg. Volume
851,486
Mkt Cap
528.83M
P/E Ratio
3.75
Dividend Yield
6.72%
Dividend
0.6

Upcoming

Dividends

6.72%Dividend Yield
Mar 26
$0.15
Dec 25
$0.15
Sep 25
$0.15
Jun 25
$0.15
Mar 25
$0.15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

8MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.36
0.61
0.87
1.12
Expected EPS
0.4166
Actual EPS
N/A

Financials

8.83%Profit Margin
Profitable
2021
2022
2023
2024
2025
2.16BRevenue
190.8MNet Income

Analyst Ratings

$25.00Average Price Target
The highest estimate is 25.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EMBC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap111.22B
Medtronic is a major player in the medical devices sector, directly competing with Embecta in the diabetes management space, including insulin pumps and glucose monitoring systems.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products, competing with Embecta in areas such as glucose monitoring.
Dexcom
DXCM
Mkt Cap24.27B
DexCom specializes in continuous glucose monitoring (CGM) systems, a direct competitor to Embecta's diabetes care products.
Tandem Diabetes Care
TNDM
Mkt Cap1.27B
Tandem Diabetes Care is a direct competitor in the insulin pump market, offering advanced diabetes management systems.
Insulet
PODD
Mkt Cap14.38B
Insulet Corporation specializes in tubeless insulin pump technology, competing in the insulin delivery market alongside Embecta.
Novo Nordisk
NVO
Mkt Cap164.13B
Novo Nordisk is a global healthcare company with a strong focus on diabetes care, including insulin and devices, competing with Embecta's offerings.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is involved in diabetes care through its insulin and glucose monitoring products, making it a competitor to Embecta.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb, through its acquisition of MyoKardia, has expanded into various healthcare sectors, potentially competing with Embecta in the broader medical devices and healthcare market.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its medical devices segment, competes in the healthcare market, including areas that overlap with Embecta's diabetes care products.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation operates in the medical devices sector, competing in various areas that could intersect with Embecta's market, including diabetes care solutions.

About

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Show more...
CEO
Mr. Devdatt Kurdikar Ph.D.
Employees
2000
Country
US
ISIN
US29082K1051

Listings

0 Comments

Share your thoughts

FAQ

What is Embecta stock price today?
The current price of EMBC is $8.93 USD — it has increased by +0.9% in the past 24 hours. Watch Embecta stock price performance more closely on the chart.
What is Embecta stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Embecta stocks are traded under the ticker EMBC.
Is Embecta stock price growing?
EMBC stock has risen by +1.02% compared to the previous week, the month change is a -1.54% fall, over the last year Embecta has showed a -26.14% decrease.
What is Embecta market cap?
Today Embecta has the market capitalization of 528.83M
When is the next Embecta earnings date?
Embecta is going to release the next earnings report on May 08, 2026.
What were Embecta earnings last quarter?
EMBC earnings for the last quarter are 0.71 USD per share, whereas the estimation was 0.67 USD resulting in a +5.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Embecta revenue for the last year?
Embecta revenue for the last year amounts to 2.16B USD.
What is Embecta net income for the last year?
EMBC net income for the last year is 190.8M USD.
Does Embecta pay dividends?
Yes, EMBC dividends are paid quarterly. The last dividend per share was 0.15 USD. As of today, Dividend Yield (FWD)% is 6.72%.
How many employees does Embecta have?
As of April 07, 2026, the company has 2,000 employees.
In which sector is Embecta located?
Embecta operates in the Health Care sector.
When did Embecta complete a stock split?
Embecta has not had any recent stock splits.
Where is Embecta headquartered?
Embecta is headquartered in Parsippany, US.